Malignant Mixed Neoplasm — Trials

Malignant Mixed Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

348 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 96
Recruiting: 48
Ph III recruiting: 12
Growth YoY: —
Industry share: 7%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (43)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05265793	Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or Carcinosarcoma	unknown	Phase 2	45	Fudan UniversityOTHER	1	Mar 4, 2022	clinicaltrials
NCT03570437	Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel?(COPELIA)	unknown	Phase 2	124	University of ManchesterOTHER	1	Mar 2, 2022	clinicaltrials